Navigation Links
Wound Management Technologies, Inc. Announces Strategic Business Directions, Recent Conference Presentation, in Addition to Symposium Exhibit Plans for Las Vegas
Date:10/29/2008

FORT WORTH, Texas, Oct. 29 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced today that the company is currently negotiating with several organizations looking to license WMT's proprietary activated collagen products for wound care management outside the United States.

"Wound Management Technologies has been working with various medical professionals to demonstrate how and why WMT's collagen products significantly outperform other collagen products on the market today. The positive results we have received from these demonstrations has generated both national and international interest and has provided us with the opportunity to bring in wound care organizations in different regions of the world as business partners," said Scott Haire, the company's Chief Executive Officer.

From a worldwide perspective, wound care is a $20 billion plus health care expenditure, explains the company's Chief Operations Officer, Bobby Stout. Stout added "We continue to examine existing and future partner relationships as a means to be able to achieve and maximize our revenues. By releasing additional evidence based studies and performing more clinical research, we believe we will continue to demonstrate why WMT's activated collagen products produce the best results on diabetic wounds, as well as other patients requiring wound management." CellerateRx(R), WMT's current activated collagen product, is FDA cleared for use on all wound types, except for 3rd degree burns and is effective in all wound phases.

Evidence of the efficacy of WMT's activated collagen was recently presented at the 9th annual New Cardiovascular Horizons (NCVH) and Management of the Diabetic Foot and Wound Healing conference, held September 10-13, 2008 in New Orleans. NCVH is one of the largest international multi-disciplinary conferences. The presentation was on Friday, September 12, 2008 during the session 2nd Annual New Therapeutic Wound Care Technology Summit: Emerging Use of Topical "Biologics" in Limb Salvage--Role of "Activated Collagen" in Multimodality Treatment. The entire presentation can be seen on the WMT's web site or using these links listed here:

Please click here to view Presentation:

http://www.newcvhorizons.com/uploads/gary%20rothenberg.pdf

For ALL presentations of the NCVH 2008 conference, click here:

http://www.newcvhorizons.com/site223.php

Wound Management Technologies, Inc., also announced today that its subsidiary, Wound Care Innovations, LLC, will exhibit at the 23rd Annual Clinical Symposium on Advances in Skin and Wound Care: The Conference for Prevention and Healing at the Rio All Suite Hotel in Las Vegas, Nevada. The Symposium is designed to enable the attendee to apply basic to advanced concepts in the science of wound healing or in preventing and managing wounds. Presented will be cutting-edge treatments, emerging technologies, and research breakthroughs which will assist clinicians in identifying credible, balanced, and relevant clinical practice issues.

"This conference is an excellent opportunity for us to present our advanced wound care product, CellerateRx(R)" states Cathy Bradshaw, President of Wound Care Innovations. "We are especially excited about this conference as there were case reports using CellerateRx(R) in the August issue of the wound care journal, Advances in Skin & Wound. The Symposium allows us to target key wound care specialists from all around the United States and international attendees as well."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at: http://www.Celleraterx.com

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Further Information:

Product Information Shareholder Relations

Cathy Bradshaw Lucy Singleton

President Secretary

954-315-9242 817-820-7080


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
2. ULURU Inc. Announces Poster Presentations at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
3. Livelihood Programs Help Heal War Wounds in Uganda
4. VA, DoD Electronically Hand Off Records of Wounded Patients
5. Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009
6. Association for the Advancement of Wound Care Leads World Health Organization Initiative to Establish Guidelines for Wound and Lymphedema Care
7. Wounded Warrior Project (WWP), St. Johns University, and Insurance Industry Charitable Foundation Partner to Assist Wounded Warriors
8. Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal
9. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
10. Michael and Terry Ward Donate $1 Million to Wounded Warrior Project (WWP)
11. Canica Design Awarded Milestone U.S. Patent for Dynamic Wound Closure Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: